3.31.23 | Autoimmune Final Policy Brief of Four-Part Series Shines Light on Need for Diversity Within Autoimmune Clinical Trials
Recognizing the significant impact that diversity has on the nation's ability to improve autoimmune outcomes and advance health equity, SWHR developed the policy brief, “The Need for Diversity in Autoimmune Disease Research Trials.”
3.31.23 | Autoimmune Third Policy Brief Highlights Role of Federal Agencies in Supporting Women with Autoimmune Diseases and Conditions
The SWHR policy brief, “Federal Agencies’ Work in Autoimmune Diseases and Conditions,” demonstrates how federal agencies are contributing to improved health and health care for women across the lifespan and why investments in these programs and initiatives should continue to be prioritized.
3.31.23 | Autoimmune Federal Agencies’ Work in Autoimmune Diseases and Conditions
The U.S. government—through its programs and initiatives—has an important role to play in improving the lives of those living with […]
3.31.23 | Autoimmune The Need for Diversity in Autoimmune Disease Research Trials
While the United States has made progress to close the gaps that have resulted from the historical exclusion of women […]
3.22.23 | Autoimmune Diversity in Autoimmune Clinical Trials: Addressing Areas of Need and Opportunity
During this SWHR Instagram Live event, hear from experts about why clinical trial representation is critical for improving outcomes, where they see the greatest issues in clinical trial representation, and if federal proposals to rectify underrepresentation of certain populations could improve involvement.
3.13.23 | Autoimmune Latest Policy Brief Highlights State of Federal Autoimmune Disease Research and Need for Continued Prioritization
The SWHR policy brief, "Prioritizing Federal Research on Autoimmune and Immune-Mediated Diseases and Conditions," discusses the state of autoimmune disease research at the federal level.
3.13.23 | Autoimmune Prioritizing Federal Research on Autoimmune and Immune-Mediated Diseases and Conditions
Autoimmune diseases are estimated to affect anywhere between 23.5 and 50 million Americans, and recent evidence has shown that the […]
3.3.23 | Autoimmune The Role of Federal Agencies in Supporting Women with Autoimmune Diseases and Conditions
During this national webinar, panelists discussed how different U.S. public health and research agencies support women with autoimmune diseases and conditions and which resources within these agencies can help women navigate their autoimmune journey.
